Dogwood Therapeutics

DWTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$51.329 M

$1.51 -5.63%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$34.3M

Loss-making

Shares outstanding

33,992,553

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#351Edesa BiotechEDSA$55.0M
#352Annovis BioANVS$53.8M
#353Dogwood TherapeuticsDWTX$51.3M
#354Filana TherapeuticsFLNA$49.8M
#355Elicio TherapeuticsELTX$49.1M

What if Dogwood Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$889,429.21

Per share 589,026× higher

Bitcoin $1.74T

$51,236.37

Per share 33,931× higher

Nvidia $5.52T

$162,263.98

Per share 107,460× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Dogwood Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.